Digital Pathology Analytic Market Report : Business Overview in COVID-19 Impact

Covid-19 Impact on Digital Pathology: Market Size, Recent Trends and future crises The COVID-19 pandemic has resulted in several disruptions to pathology over the last few months. Changes in caseloads and workflows are likely to continue for some time, and pressures could increase further with an influx of delayed cancer diagnoses once screening programs resume and people who have been holding off making appointments go to see their doctors.

Note: To learn more about the impact the COVID-19 pandemic is having on pathology, what the future of pathology might look like, and how digital pathology could help to ease some of the challenges Visit us: https://www.databridgemarketresearch.com/covid-19-resources/covid19-impact-on-digital-pathology-in-the-healthcare-industry In current clinical practices, digital pathology technology has been instrumental. In the background of the latest Coronavirus outbreak, it has become more important resource in the research laboratory ecosystems and is gaining traction recently. Although it was initially created as a cost-effective pathological method to help pathologies achieve better efficiency, The COVID-19 crisis immediately led to a rising demand for digital pathology, and the pathology industry’s fate may forever be changed.

The fast-moving Coronavirus disease (COVID-19) of 2019 affects all of us severely. The most significant descriptions of how we live our lives are terms such as "social distancing," "selfquarantine," and "flattening the curve." Hopefully, this pandemic will soon be resolved, but its permanent effects will change the way we live and work. We are becoming increasingly used to remote and practical technologies. Although we will ultimately return to our daily activities, we will rely on these approaches for the complexities of the post-COVID-19 world in many working environments.

The global digital pathology market is projected to reach USD 1,139 million by 2025 from USD 613 million in 2020, at a CAGR of 13.2% during the forecast period. The growth of this market is majorly attributed to the increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, and the growing application of digital pathology in drug development & companion diagnostics. However, a lack of trained pathologists is expected to challenge market growth in the coming years.

Digital Pathology is on show but the pathologies are still huge. The automation of laboratories is now under way. Burges in the field of imagery technologies, such as entire diaphragm imaging (WSI), software applications, LIS and LIMS (in routine workflows) in lab information and management systems and networking advances have enabled pathology digitization.

COVID-19 creates a great need for the remote working of pathologists which leads to a prolific demand for digital pathologies. The future development of digital pathology environments is further complemented by recent regulatory developments.

COVID-19 pandemic has a profound impact on routine pathology services.1 Digital pathology can play a role ‘to safeguarding clinical services and pathology-based research in the current climate and in the future’.1 This digital-based approach to diagnosis represents a new way in the evaluation of surgical pathology slides from formalin-fixed paraffin-embedded tissue (FFPE). It makes the pathologist free from the constraints of using an optical microscope in his/her office.

At the same time, it can have an effect on ‘social interaction’ among pathologists, including their interplay with clinicians and even patients. A recent contribution from our group briefly dealt with the changing aspects of such a relationship at the peak of the COVID-19 pandemic.2 The aim was to try to foresee how the kind of experience acquired during the pandemic could have influenced the approach to histopathology in the digital and postdigital eras.

The COVID-19 pandemic has had a surprising impact for histology and digital pathology. The pandemic has curtailed all but the most serious surgeries and cancer treatments. Thus the histology lab is receiving the most difficult of tissue samples to process. There is also a workforce shortage of pathologists, with more pathologists retiring than those entering the field and with physical distancing many pathologists are staying out of the lab. At the same time new rules allow greater use of digital pathology as well as the reading of the test results from remote locations as long as the test was first performed in an authorized CLIA laboratory.

FOLLOWING IN THE MIDST OF THE CRISIS @ https://www.databridgemarketresearch.com/covid-19-resources/covid-19-impact-ondigital-pathology-in-the-healthcare-industry Many companies in digital pathology now offer a broad range of devices for remote dialing or image sharing, as vendor sponsors cover the general spectrum of what's available here on Tissue Pathology. However, because COVID-19 has greatly accelerated the digitization times in many hospitals, some organizations can only now seriously consider digital resources. The choices can be daunting and so you can search the options available by assembling a list of the principal kinds of digital resources.

Digital Scanned Slides – It appears that the most obvious solution to the term "digital workflow" is that for second opinions, education and training, digital slides can be scanned and exchanged online, and sign-outs may be made for systems approved by the FDA. Cloud Consulting Platforms – Cloud technologies can be used to cross the physical gap between sites to start work, whether humanitarian or otherwise. One notable success story is the ASCP Partner in Cancer Diagnostics Program.

Live Image Scanners – Some scanning systems can also turn into robotic microscopes that can be remotely, in real time monitored and operated, so that the scan does not have to be done.

These systems enable the disease to retain complete control of the sample and focus it on and may especially be useful for rapid assessments or where the sample is thick or uneven.

Microscopy Video – The easiest digital instrument: mount a camera on a microscope to stream the pathologist’s image via video chat. In the field of pathologist control, a trainee expert (a fellow cytotechnician, resident or senior cytotechnician) is required.

How can the research study help your business?

1. Which Digital Pathology segment to account for the largest share in 2020?

2. Which is the leading end user for digital pathology market?

3. What are the opportunistic areas available for new and existing players in the digital pathology market to enhance their market share?

4. Who are the key players operating in the global digital pathology market?

Market Research Related Blogs 

Global digital pathology market to witness high demand due to rising cases of cancer worldwide